Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action

Aminu K. Bello, Mona Alrukhaimi, Gloria E. Ashuntantang, Shakti Basnet, Ricardo C. Rotter, Walter G. Douthat, Rumeyza Kazancioglu, Anna Köttgen, Masaomi Nangaku, Neil R. Powe, Sarah L. White, David C. Wheeler, Orson Moe

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

The International Society of Nephrology has adopted a proactive approach to defining the current state of kidney care and unmet needs through a multifaceted Closing the Gaps initiative. As part of this initiative, the International Society of Nephrology convened a meeting of experts to develop an approach to tackle acute kidney injury and chronic kidney disease (CKD). This manuscript expands on the recently published International Society of Nephrology CKD Roadmap and reports on the discussions of the working group assigned to the task of reviewing the global impact of complication of CKD. The working group defined the following goals: Goal 1: Optimize the management of anemia and endocrine and metabolic abnormalities associated with CKD. The impact of these conditions at a global level is not well understood, particularly in regions where renal replacement therapy is not readily available. Some treatment regimens may be affordable in low- and middle-income countries and if implemented, could have an impact on the burden of suffering associated with CKD. Goal 2: Improve the prevention and management of cardiovascular complications linked to CKD. Most research on cardiovascular complications of CKD has focused on atherosclerotic diseases (myocardial infarction, ischemic stroke, and peripheral gangrene). There has been growing recognition that other forms of cardiovascular diseases, such as heart failure, valvular disease and arrhythmias, have a major impact on patient outcomes. Much less is known about the mechanisms and treatment of these non-atherosclerotic complications. Goal 3: Improve the diagnosis and management of symptoms associated with CKD. Symptom management is one of the greatest challenges in the management of CKD, with limited knowledge about the mechanisms associated with the development of these common problems and how best to characterize them into usable clinical phenotypes. Improved understanding of the complications of CKD may alleviate suffering and prolong life among millions of people worldwide both in developed countries and in regions where renal replacement therapy is not widely available.

Original languageEnglish (US)
Pages (from-to)122-129
Number of pages8
JournalKidney International Supplements
Volume7
Issue number2
DOIs
StatePublished - Oct 1 2017

Fingerprint

Chronic Renal Insufficiency
Renal Replacement Therapy
Gangrene
Psychological Stress
Acute Kidney Injury
Developed Countries
Cardiac Arrhythmias
Anemia
Cardiovascular Diseases
Heart Failure
Stroke
Myocardial Infarction
Phenotype
Kidney
Therapeutics

Keywords

  • CKD
  • complications
  • knowledge gaps
  • management
  • mechanisms

ASJC Scopus subject areas

  • Nephrology

Cite this

Complications of chronic kidney disease : current state, knowledge gaps, and strategy for action. / Bello, Aminu K.; Alrukhaimi, Mona; Ashuntantang, Gloria E.; Basnet, Shakti; Rotter, Ricardo C.; Douthat, Walter G.; Kazancioglu, Rumeyza; Köttgen, Anna; Nangaku, Masaomi; Powe, Neil R.; White, Sarah L.; Wheeler, David C.; Moe, Orson.

In: Kidney International Supplements, Vol. 7, No. 2, 01.10.2017, p. 122-129.

Research output: Contribution to journalReview article

Bello, AK, Alrukhaimi, M, Ashuntantang, GE, Basnet, S, Rotter, RC, Douthat, WG, Kazancioglu, R, Köttgen, A, Nangaku, M, Powe, NR, White, SL, Wheeler, DC & Moe, O 2017, 'Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action', Kidney International Supplements, vol. 7, no. 2, pp. 122-129. https://doi.org/10.1016/j.kisu.2017.07.007
Bello, Aminu K. ; Alrukhaimi, Mona ; Ashuntantang, Gloria E. ; Basnet, Shakti ; Rotter, Ricardo C. ; Douthat, Walter G. ; Kazancioglu, Rumeyza ; Köttgen, Anna ; Nangaku, Masaomi ; Powe, Neil R. ; White, Sarah L. ; Wheeler, David C. ; Moe, Orson. / Complications of chronic kidney disease : current state, knowledge gaps, and strategy for action. In: Kidney International Supplements. 2017 ; Vol. 7, No. 2. pp. 122-129.
@article{68f65d4581ad4775840a649007667452,
title = "Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action",
abstract = "The International Society of Nephrology has adopted a proactive approach to defining the current state of kidney care and unmet needs through a multifaceted Closing the Gaps initiative. As part of this initiative, the International Society of Nephrology convened a meeting of experts to develop an approach to tackle acute kidney injury and chronic kidney disease (CKD). This manuscript expands on the recently published International Society of Nephrology CKD Roadmap and reports on the discussions of the working group assigned to the task of reviewing the global impact of complication of CKD. The working group defined the following goals: Goal 1: Optimize the management of anemia and endocrine and metabolic abnormalities associated with CKD. The impact of these conditions at a global level is not well understood, particularly in regions where renal replacement therapy is not readily available. Some treatment regimens may be affordable in low- and middle-income countries and if implemented, could have an impact on the burden of suffering associated with CKD. Goal 2: Improve the prevention and management of cardiovascular complications linked to CKD. Most research on cardiovascular complications of CKD has focused on atherosclerotic diseases (myocardial infarction, ischemic stroke, and peripheral gangrene). There has been growing recognition that other forms of cardiovascular diseases, such as heart failure, valvular disease and arrhythmias, have a major impact on patient outcomes. Much less is known about the mechanisms and treatment of these non-atherosclerotic complications. Goal 3: Improve the diagnosis and management of symptoms associated with CKD. Symptom management is one of the greatest challenges in the management of CKD, with limited knowledge about the mechanisms associated with the development of these common problems and how best to characterize them into usable clinical phenotypes. Improved understanding of the complications of CKD may alleviate suffering and prolong life among millions of people worldwide both in developed countries and in regions where renal replacement therapy is not widely available.",
keywords = "CKD, complications, knowledge gaps, management, mechanisms",
author = "Bello, {Aminu K.} and Mona Alrukhaimi and Ashuntantang, {Gloria E.} and Shakti Basnet and Rotter, {Ricardo C.} and Douthat, {Walter G.} and Rumeyza Kazancioglu and Anna K{\"o}ttgen and Masaomi Nangaku and Powe, {Neil R.} and White, {Sarah L.} and Wheeler, {David C.} and Orson Moe",
year = "2017",
month = "10",
day = "1",
doi = "10.1016/j.kisu.2017.07.007",
language = "English (US)",
volume = "7",
pages = "122--129",
journal = "Kidney International Supplements",
issn = "2157-1724",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Complications of chronic kidney disease

T2 - current state, knowledge gaps, and strategy for action

AU - Bello, Aminu K.

AU - Alrukhaimi, Mona

AU - Ashuntantang, Gloria E.

AU - Basnet, Shakti

AU - Rotter, Ricardo C.

AU - Douthat, Walter G.

AU - Kazancioglu, Rumeyza

AU - Köttgen, Anna

AU - Nangaku, Masaomi

AU - Powe, Neil R.

AU - White, Sarah L.

AU - Wheeler, David C.

AU - Moe, Orson

PY - 2017/10/1

Y1 - 2017/10/1

N2 - The International Society of Nephrology has adopted a proactive approach to defining the current state of kidney care and unmet needs through a multifaceted Closing the Gaps initiative. As part of this initiative, the International Society of Nephrology convened a meeting of experts to develop an approach to tackle acute kidney injury and chronic kidney disease (CKD). This manuscript expands on the recently published International Society of Nephrology CKD Roadmap and reports on the discussions of the working group assigned to the task of reviewing the global impact of complication of CKD. The working group defined the following goals: Goal 1: Optimize the management of anemia and endocrine and metabolic abnormalities associated with CKD. The impact of these conditions at a global level is not well understood, particularly in regions where renal replacement therapy is not readily available. Some treatment regimens may be affordable in low- and middle-income countries and if implemented, could have an impact on the burden of suffering associated with CKD. Goal 2: Improve the prevention and management of cardiovascular complications linked to CKD. Most research on cardiovascular complications of CKD has focused on atherosclerotic diseases (myocardial infarction, ischemic stroke, and peripheral gangrene). There has been growing recognition that other forms of cardiovascular diseases, such as heart failure, valvular disease and arrhythmias, have a major impact on patient outcomes. Much less is known about the mechanisms and treatment of these non-atherosclerotic complications. Goal 3: Improve the diagnosis and management of symptoms associated with CKD. Symptom management is one of the greatest challenges in the management of CKD, with limited knowledge about the mechanisms associated with the development of these common problems and how best to characterize them into usable clinical phenotypes. Improved understanding of the complications of CKD may alleviate suffering and prolong life among millions of people worldwide both in developed countries and in regions where renal replacement therapy is not widely available.

AB - The International Society of Nephrology has adopted a proactive approach to defining the current state of kidney care and unmet needs through a multifaceted Closing the Gaps initiative. As part of this initiative, the International Society of Nephrology convened a meeting of experts to develop an approach to tackle acute kidney injury and chronic kidney disease (CKD). This manuscript expands on the recently published International Society of Nephrology CKD Roadmap and reports on the discussions of the working group assigned to the task of reviewing the global impact of complication of CKD. The working group defined the following goals: Goal 1: Optimize the management of anemia and endocrine and metabolic abnormalities associated with CKD. The impact of these conditions at a global level is not well understood, particularly in regions where renal replacement therapy is not readily available. Some treatment regimens may be affordable in low- and middle-income countries and if implemented, could have an impact on the burden of suffering associated with CKD. Goal 2: Improve the prevention and management of cardiovascular complications linked to CKD. Most research on cardiovascular complications of CKD has focused on atherosclerotic diseases (myocardial infarction, ischemic stroke, and peripheral gangrene). There has been growing recognition that other forms of cardiovascular diseases, such as heart failure, valvular disease and arrhythmias, have a major impact on patient outcomes. Much less is known about the mechanisms and treatment of these non-atherosclerotic complications. Goal 3: Improve the diagnosis and management of symptoms associated with CKD. Symptom management is one of the greatest challenges in the management of CKD, with limited knowledge about the mechanisms associated with the development of these common problems and how best to characterize them into usable clinical phenotypes. Improved understanding of the complications of CKD may alleviate suffering and prolong life among millions of people worldwide both in developed countries and in regions where renal replacement therapy is not widely available.

KW - CKD

KW - complications

KW - knowledge gaps

KW - management

KW - mechanisms

UR - http://www.scopus.com/inward/record.url?scp=85031733984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031733984&partnerID=8YFLogxK

U2 - 10.1016/j.kisu.2017.07.007

DO - 10.1016/j.kisu.2017.07.007

M3 - Review article

C2 - 30675426

AN - SCOPUS:85031733984

VL - 7

SP - 122

EP - 129

JO - Kidney International Supplements

JF - Kidney International Supplements

SN - 2157-1724

IS - 2

ER -